Cargando…
decompTumor2Sig: identification of mutational signatures active in individual tumors
BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472187/ https://www.ncbi.nlm.nih.gov/pubmed/30999866 http://dx.doi.org/10.1186/s12859-019-2688-6 |
_version_ | 1783412194892840960 |
---|---|
author | Krüger, Sandra Piro, Rosario M. |
author_facet | Krüger, Sandra Piro, Rosario M. |
author_sort | Krüger, Sandra |
collection | PubMed |
description | BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of such mutational processes can be modeled by mutational signatures, of which two different conceptualizations exist: the model introduced by Alexandrov et al., Nature 500:415–421, 2013, and the model introduced by Shiraishi et al., PLoS Genetics 11(12):e1005657, 2015. The initial identification and definition of mutational signatures requires large sets of tumor samples. RESULTS: Here, we present decompTumor2Sig, an easy to use R package that can decompose an individual tumor genome into a given set of Alexandrov-type or Shiraishi-type signatures, thus quantifying the contribution of the corresponding mutational processes to the somatic mutations identified in the tumor. Until now, such tools were available only for Alexandrov signatures. We demonstrate the correctness and usefulness of our approach with three test cases, using somatic mutations from 21 breast cancer genomes, from 435 tumor genomes of ten different tumor entities, and from simulated tumor genomes, respectively. CONCLUSIONS: The decompTumor2Sig package is freely available and has been accepted for inclusion in Bioconductor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2688-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6472187 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64721872019-04-24 decompTumor2Sig: identification of mutational signatures active in individual tumors Krüger, Sandra Piro, Rosario M. BMC Bioinformatics Research BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of such mutational processes can be modeled by mutational signatures, of which two different conceptualizations exist: the model introduced by Alexandrov et al., Nature 500:415–421, 2013, and the model introduced by Shiraishi et al., PLoS Genetics 11(12):e1005657, 2015. The initial identification and definition of mutational signatures requires large sets of tumor samples. RESULTS: Here, we present decompTumor2Sig, an easy to use R package that can decompose an individual tumor genome into a given set of Alexandrov-type or Shiraishi-type signatures, thus quantifying the contribution of the corresponding mutational processes to the somatic mutations identified in the tumor. Until now, such tools were available only for Alexandrov signatures. We demonstrate the correctness and usefulness of our approach with three test cases, using somatic mutations from 21 breast cancer genomes, from 435 tumor genomes of ten different tumor entities, and from simulated tumor genomes, respectively. CONCLUSIONS: The decompTumor2Sig package is freely available and has been accepted for inclusion in Bioconductor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2688-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-18 /pmc/articles/PMC6472187/ /pubmed/30999866 http://dx.doi.org/10.1186/s12859-019-2688-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Krüger, Sandra Piro, Rosario M. decompTumor2Sig: identification of mutational signatures active in individual tumors |
title | decompTumor2Sig: identification of mutational signatures active in individual tumors |
title_full | decompTumor2Sig: identification of mutational signatures active in individual tumors |
title_fullStr | decompTumor2Sig: identification of mutational signatures active in individual tumors |
title_full_unstemmed | decompTumor2Sig: identification of mutational signatures active in individual tumors |
title_short | decompTumor2Sig: identification of mutational signatures active in individual tumors |
title_sort | decomptumor2sig: identification of mutational signatures active in individual tumors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472187/ https://www.ncbi.nlm.nih.gov/pubmed/30999866 http://dx.doi.org/10.1186/s12859-019-2688-6 |
work_keys_str_mv | AT krugersandra decomptumor2sigidentificationofmutationalsignaturesactiveinindividualtumors AT pirorosariom decomptumor2sigidentificationofmutationalsignaturesactiveinindividualtumors |